• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nike, AAR And 3 Stocks To Watch Heading Into Friday

    12/22/23 4:37:59 AM ET
    $AIR
    $GLTO
    $MPC
    $NKE
    Aerospace
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AIR alert in real time by email

    With U.S. stock futures trading lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:

    NIKE, Inc. (NYSE:NKE) posted better-than-expected earnings for its second quarter, but sales missed expectations. The company also stated that it is assessing opportunities to deliver up to $2 billion in cumulative cost savings during the next three years. Nike shares dipped 11.7% to $108.21 in after-hours trading.

    Rocket Lab USA, Inc. (NASDAQ:RKLB) shares rose sharply in after-hours trading on Thursday after the company announced a new $515 million contract with a U.S. government customer. Rocket Lab shares jumped 15.6% to $5.12 in the after-hours trading session.

    Marathon Petroleum Corporation (NYSE:MPC) named Maryann Mannen as President and John Quaid as Executive Vice President and CFO. Marathon Petroleum shares gained 0.4% to $153.33 in after-hours trading.

    Check out our premarket coverage here

    AAR Corp. (NYSE:AIR) posted upbeat earnings for its second quarter, while sales missed estimates. AAR shares fell 1.4% to $69.80 in the after-hours trading session.

    Galecto, Inc. (NASDAQ:GLTO) shares surged in after-hours trading after the company announced topline results from a Phase 2a trial of GB2064 for the treatment of myelofibrosis. Galecto shares jumped 16% to $0.7187 in the after-hours trading session.

    Check This Out: How To Earn $500 A Month From Broadcom Stock Following Recent Rally

    Get the next $AIR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIR
    $GLTO
    $MPC
    $NKE

    CompanyDatePrice TargetRatingAnalyst
    Marathon Petroleum Corporation
    $MPC
    2/4/2026$183.00 → $198.00Buy
    TD Cowen
    AAR Corp.
    $AIR
    1/26/2026$121.00Neutral
    Goldman
    Rocket Lab Corporation
    $RKLB
    1/16/2026$105.00Equal-Weight → Overweight
    Morgan Stanley
    Rocket Lab Corporation
    $RKLB
    1/15/2026Overweight → Sector Weight
    KeyBanc Capital Markets
    Nike Inc.
    $NKE
    1/8/2026Hold
    Deutsche Bank
    Nike Inc.
    $NKE
    1/8/2026Buy → Hold
    Needham
    Galecto Inc.
    $GLTO
    1/7/2026$46.00Outperform
    Leerink Partners
    Nike Inc.
    $NKE
    12/19/2025$75.00 → $72.00Market Perform
    Telsey Advisory Group
    More analyst ratings

    $AIR
    $GLTO
    $MPC
    $NKE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on Marathon Petroleum with a new price target

    TD Cowen reiterated coverage of Marathon Petroleum with a rating of Buy and set a new price target of $198.00 from $183.00 previously

    2/4/26 7:58:31 AM ET
    $MPC
    Integrated oil Companies
    Energy

    Goldman initiated coverage on AAR Corp with a new price target

    Goldman initiated coverage of AAR Corp with a rating of Neutral and set a new price target of $121.00

    1/26/26 10:01:23 AM ET
    $AIR
    Aerospace
    Industrials

    Rocket Lab USA upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Rocket Lab USA from Equal-Weight to Overweight and set a new price target of $105.00

    1/16/26 8:21:34 AM ET
    $RKLB
    Military/Government/Technical
    Industrials

    $AIR
    $GLTO
    $MPC
    $NKE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Rocket Lab Prepares To Launch Latest Hypersonic Test Mission for Defense Innovation Unit

    LONG BEACH, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or "the Company"), a global leader in launch services and space systems, today announced its next launch is a dedicated mission on its HASTE rocket for the Department of War's Defense Innovation Unit (DIU). The mission, named Cassowary Vex, is scheduled to launch no earlier than late February from Rocket Lab Launch Complex 2 within the Virginia Spaceport Authority's Mid-Atlantic Regional Spaceport on Wallops Island, Virginia. The HASTE launch, dubbed ‘That's Not A Knife," is the latest mission of the DIU and will deploy DART AE, a scramjet-powered aircraft developed by Australian aero

    2/12/26 4:30:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Galecto Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $316.3 Million

    BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ:GLTO), a biopharmaceutical company focused on developing novel therapeutics to redefine the treatment paradigm for people living with blood cancers, today announced the closing of its previously announced underwritten public offering of 16,644,737 shares of its common stock, including the full exercise of the underwriters' option to purchase up to 2,171,052 additional shares, at a public offering price of $19.00 per share. The aggregate gross proceeds to Galecto from the offering were approximately $316.3 million, before deducting underwriting discounts and commissions and offering expenses payable by Galecto. Jefferies, Leer

    2/12/26 4:01:00 PM ET
    $GLTO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    AAR appoints Dylan Wolin as Chief Financial Officer

    WOOD DALE, Ill., Feb. 11, 2026 /PRNewswire/ -- AAR CORP. (NYSE:AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, announced today that its Board of Directors has appointed Dylan Wolin as the Company's Chief Financial Officer, effective February 23, 2026. Wolin's responsibilities will include finance, accounting, tax, treasury, investor relations, and corporate development. "I am eager to partner with John and the rest of the AAR team to drive continued execution of AAR's growth strategy."Wolin will rejoin AAR from Federal Sign

    2/11/26 4:30:00 PM ET
    $AIR
    Aerospace
    Industrials

    $AIR
    $GLTO
    $MPC
    $NKE
    SEC Filings

    View All

    SEC Form 144 filed by Marathon Petroleum Corporation

    144 - Marathon Petroleum Corp (0001510295) (Subject)

    2/12/26 1:42:33 PM ET
    $MPC
    Integrated oil Companies
    Energy

    Amendment: SEC Form SCHEDULE 13D/A filed by Galecto Inc.

    SCHEDULE 13D/A - Galecto, Inc. (0001800315) (Subject)

    2/11/26 6:11:02 PM ET
    $GLTO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 8-K filed by Galecto Inc.

    8-K - Galecto, Inc. (0001800315) (Filer)

    2/11/26 5:10:21 PM ET
    $GLTO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIR
    $GLTO
    $MPC
    $NKE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    PRESIDENT & CEO Hill Elliott bought $1,001,307 worth of Class B Common Stock (16,388 units at $61.10), increasing direct ownership by 7% to 241,587 units (SEC Form 4)

    4 - NIKE, Inc. (0000320187) (Issuer)

    12/30/25 4:23:10 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    Director Cook Timothy D bought $2,948,500 worth of Class B Common Stock (50,000 units at $58.97), increasing direct ownership by 90% to 105,480 units (SEC Form 4)

    4 - NIKE, Inc. (0000320187) (Issuer)

    12/23/25 4:25:32 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    Director Swan Robert Holmes bought $500,080 worth of Class B Common Stock (8,691 units at $57.54), increasing direct ownership by 25% to 43,293 units (SEC Form 4)

    4 - NIKE, Inc. (0000320187) (Issuer)

    12/23/25 4:21:15 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    $AIR
    $GLTO
    $MPC
    $NKE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP: Chief Legal Officer Leinwand Robert covered exercise/tax liability with 4,647 units of Class B Common Stock, decreasing direct ownership by 6% to 70,727 units (SEC Form 4)

    4 - NIKE, Inc. (0000320187) (Issuer)

    2/12/26 4:16:13 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    EVP: CHIEF PEOPLE OFFICER Heinle Treasure covered exercise/tax liability with 853 units of Class B Common Stock, decreasing direct ownership by 1% to 59,759 units (SEC Form 4)

    4 - NIKE, Inc. (0000320187) (Issuer)

    2/12/26 4:15:24 PM ET
    $NKE
    Shoe Manufacturing
    Consumer Discretionary

    Director Bruno Julianne converted options into 129,000 shares, increasing direct ownership by 1,606% to 137,032 units (SEC Form 4)

    4 - Galecto, Inc. (0001800315) (Issuer)

    2/12/26 6:05:08 AM ET
    $GLTO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIR
    $GLTO
    $MPC
    $NKE
    Leadership Updates

    Live Leadership Updates

    View All

    AAR appoints Dylan Wolin as Chief Financial Officer

    WOOD DALE, Ill., Feb. 11, 2026 /PRNewswire/ -- AAR CORP. (NYSE:AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, announced today that its Board of Directors has appointed Dylan Wolin as the Company's Chief Financial Officer, effective February 23, 2026. Wolin's responsibilities will include finance, accounting, tax, treasury, investor relations, and corporate development. "I am eager to partner with John and the rest of the AAR team to drive continued execution of AAR's growth strategy."Wolin will rejoin AAR from Federal Sign

    2/11/26 4:30:00 PM ET
    $AIR
    Aerospace
    Industrials

    AAR celebrates Airframe MRO expansion in Oklahoma City, prepares to induct additional Alaska Airlines aircraft

    WOOD DALE, Ill., Jan. 28, 2026 /PRNewswire/ -- AAR CORP. (NYSE:AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, has substantially completed the expansion of its Airframe MRO facility in Oklahoma City. "We are very grateful for Alaska's trust and for the outstanding support we have received in Oklahoma City," said HolmesDriven by an increased demand for AAR's MRO services, the 80,000+ square foot facility expansion includes three maintenance bays capable of accommodating all 737 variants. The Company will soon induct addition

    1/28/26 4:30:00 PM ET
    $AIR
    Aerospace
    Industrials

    Galecto Highlights Key Strategic Priorities and Anticipated 2026 Milestones

    DMR-001, a potentially best-in-class mutant calreticulin ("mutCALR") targeting monoclonal antibody, on track for expected IND submission, or equivalent, in mid-2026 with anticipated first-in-human dosing via subcutaneous administrationRecent addition of deep hematology/oncology drug development experience with the appointment of a Chief Operating Officer and Chief Medical OfficerPipeline of additional candidates advancing to the clinic, with first IND submission of DMR-002 expected in second half of 2026Cash balance, following $285M raised in the November PIPE, provides financial runway into 2029 to support multiple data milestones, including Ph1 clinical proof-of-concept data for DMR-001 an

    1/12/26 8:00:00 AM ET
    $GLTO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIR
    $GLTO
    $MPC
    $NKE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

    SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

    12/5/24 9:49:25 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

    SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

    12/3/24 9:39:57 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Amendment: SEC Form SC 13G/A filed by Rocket Lab USA Inc.

    SC 13G/A - Rocket Lab USA, Inc. (0001819994) (Subject)

    11/12/24 4:45:55 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    $AIR
    $GLTO
    $MPC
    $NKE
    Financials

    Live finance-specific insights

    View All

    MPLX LP Reports Fourth-Quarter and Full-Year 2025 Results

    FINDLAY, Ohio, Feb. 3, 2026 /PRNewswire/ -- Full-year 2025 net income attributable to MPLX of $4.9 billion and adjusted EBITDA of $7.0 billionFull-year 2025 growth investments of $5.5 billion and capital returned to unitholders of $4.4 billion, delivering on capital return commitmentProgressing natural gas and NGL value chains through construction of Gulf Coast fractionation and export facilities and integration of sour gas treating platformAnnouncing 2026 organic growth capital plan of $2.4 billion, aligned with natural gas and NGL investments driving mid-single digit adjusted EBITDA growthMPLX LP (NYSE:MPLX) today reported fourth-quarter 2025 net income attributable to MPLX of $1,193 mill

    2/3/26 6:30:00 AM ET
    $MPC
    $MPLX
    Integrated oil Companies
    Energy
    Natural Gas Distribution

    Marathon Petroleum Corp. Reports Fourth-Quarter and Full-Year 2025 Results

    FINDLAY, Ohio, Feb. 3, 2026 /PRNewswire/ --  Fourth-quarter net income attributable to MPC of $1.5 billion, or $5.12 per diluted share, adjusted net income of $1.2 billion, or $4.07 per diluted shareFull-year refining utilization of 94 percent and margin capture of 105 percent, demonstrating strong operational and commercial performanceCash from operations of $8.3 billion enabled peer-leading capital returns of $4.5 billion in 2025 MPLX's growing distribution is expected to more than fund MPC's 2026 dividend and standalone capital; a source of differentiation for capital returnMarathon Petroleum Corp. (NYSE: MPC) today reported net income attributable to MPC of $1.5 billion, or $5.12 per di

    2/3/26 6:30:00 AM ET
    $MPC
    Integrated oil Companies
    Energy

    Marathon Petroleum Corp. Announces Quarterly Dividend

    FINDLAY, Ohio, Jan. 30, 2026 /PRNewswire/ -- The board of directors of Marathon Petroleum Corp. (NYSE:MPC) has declared a dividend of $1.00 per share on common stock. The dividend is payable March 10, 2026, to shareholders of record as of the close of business Feb. 18, 2026. About Marathon Petroleum Corporation Marathon Petroleum Corporation (MPC) is a leading, integrated, downstream and midstream energy company headquartered in Findlay, Ohio. The company operates the nation's largest refining system. MPC's marketing system includes branded locations across the United States, including Marathon brand retail outlets. MPC also owns the general partner and majority limited partner interest in

    1/30/26 4:30:00 PM ET
    $MPC
    Integrated oil Companies
    Energy